Ranibizumab Ocular Implant Shows Long-Term Benefits in Retinal Disease

(MedPage Today) -- The ranibizumab ocular implant (Susvimo) reduces the need for frequent intravitreal anti-VEGF injections in patients with neovascular age-related macular degeneration or diabetic macular edema, and structural updates to the device...